Primary Record
PAC-1
- In stock
- 5,074 g
- Purity
- 99.6 %
- CAS
- 315183-21-2
Compound Identifiers & Properties
- CAS
- 315183-21-2
- PubChem CID
- 135421197
- SMILES
- C=CCC1=C(C(=CC=C1)/C=N/NC(=O)CN2CCN(CC2)CC3=CC=CC=C3)O
- Canonical SMILES
- C=CCc1cccc(/C=N/NC(=O)CN2CCN(Cc3ccccc3)CC2)c1O
Names & Synonyms
- PAC-1
- PAC 1
- 315183-21-2
- PAC1
- Procaspase-3 Activator
- UNII-9LIS8N0B2C
- Procaspase activating compound 1
- 9LIS8N0B2C
- pac-1?
- PAC-1 pound notPAC1
- AC1NT3IP
- AC1O9ALD
- AC1OA9GH
- ZYS1
- RefChem:169429
- CBMicro_035200
- Procaspase-activating compound 1
- D01YIF
- C23H28N4O2
- ZYS-1
- cc-276
- Procaspase-3 Activator, PAC-1
- DTXSID30897425
- MFCD03302441
- CHEMBL591429
- orb1305385
- SCHEMBL9908784
- PAC-1-[d8]
- SCHEMBL29349526
- (E)-PAC-1
- BDBM36363
- CHEBI:231696
- PAC-1 VO-100
- XSGXRYNZNGUGEJ-LTGZKZEYSA-N
- DTXCID401326768
- GLXC-05218
- HMS3263J04
- HMS3413J03
- HMS3650O04
- HMS3677J03
- CID6851947
- EX-A2122
- first procaspase activating compound
- Tox21_501241
- HB1291
- MFCD02051977
- NSC743444
- NSC856629
- s2738
- VO-100
- ZINC31830150
- AKOS024457180
- (E)-N'-(3-allyl-2-hydroxybenzylidene)-2-(4-benzylpiperazin-1-yl)acetohydrazide
- BCP9001044
- BLP-003716
- CCG-222545
- CID5344054
- CID6753378
- CS-3498
- DB13048
- FP15826
- NSC-743444
- NSC-856629
- RL03112
- SDCCGSBI-0633812.P001
- PAC-1, >=98% (HPLC)
- NCGC00167785-01
- NCGC00261926-01
- AC-32078
- AS-19239
- BC644899
- DA-66443
- HY-13523
- Procaspase Activating Compound-1 VO-100
- BCP0726000262
- RT-014922
- A8177
- NS00071670
- X5905
- J2.603.303I
- 2-(4-Benzylpiperazin-1-yl)-N-((2-hydroxy-3-prop-2-enyl-phenyl)methylideneamino)acetamide
- A11090
- A12412
- Z-3306
- 1044929-62-5
- 1-Piperazineacetic acid, 4-(phenylmethyl)-, ((2-hydroxy-3-(2-propenyl)phenyl)methylene)hydrazide
- A875881
- SR-02000000933
- 1-Piperazineacetic acid, 4-(phenylmethyl)-, 2-((2-hydroxy-3-(2-propen-1-yl)phenyl)methylene)hydrazide
- SR-02000000933-2
- BRD-K50841342-001-01-6
- BRD-K92991072-001-01-5
- BRD-K92991072-001-04-9
- BRD-K92991072-001-05-6
- methylene]hydrazide; Procaspase Activating Compound 1
- 1287241-26-2
- N'-(3-allyl-2-hydroxybenzylidene)-2-(4-benzylpiperazin-1-yl)acetohydrazide
- PAC-1, 98%, a procaspase-3 activatior - 25MG 25mg
- 2-(4-benzylpiperazin-1-yl)-N-[(E)-(2-hydroxy-3-prop-2-enylphenyl)methylideneamino]acetamide
- (4-Benzylpiperazino)acetic acid-(3-allyl-2-hydroxybenzylidene)hydrazide
- 4-(Phenylmethyl)-1-piperazineacetic acid [[2-hydroxy-3-(2-propenyl)phenyl]methylene]hydrazide
- PAC 1 pound not Procaspase activating compound 1, 315183-21-2
- 2-(4-benzylpiperazin-1-yl)-N'-[(1E)-[2-hydroxy-3-(prop-2-en-1-yl)phenyl]methylidene]acetohydrazide
- 2-(4-benzylpiperazin-1-yl)-N'-[(Z)-(6-oxo-5-prop-2-enylcyclohexa-2,4-dien-1-ylidene)methyl]acetohydrazide
- N -(2-Hydroxy-3-allylbenzylidene)(4-benzylpiperazino)acetohydrazide
- N -[2-Hydroxy-3-allylbenzylidene]-4-benzylpiperazine-1-acetohydrazide
- 2-allyl-6-[(E)-[[2-(4-benzylpiperazin-1-ium-1-yl)acetyl]hydrazono]methyl]phenolate
- 4-(Phenylmethyl)-1-piperazineacetic Acid 2-[[2-Hydroxy-3-(2-propen-1-yl)phenyl]
- 4-(Phenylmethyl)-1-piperazineaceticacid[[2-hydroxy-3-(2-propenyl)phenyl]methylene]hydrazide
- 4-BENZYL-1-PIPERAZINEACETIC ACID [[2-HYDROXY-3-(2-ALLYL)PHENYL]METHYLENE]HYDRAZIDE
- N -(2-Hydroxy-3-allylbenzylidene)-2-(4-benzylpiperazine-1-yl)acetohydrazide
- N -[2-Hydroxy-3-(2-propenyl)-benzylidene]-2-(4-benzylpiperazine-1-yl)acetohydrazide
- N'-(3-allyl-2-hydroxybenzylidene)-2-(4-benzylpiperazin-1-yl)acEthanolydrazide
- N'-[(1Z)-(3-allyl-2-hydroxyphenyl)methylene]-2-(4-benzylpiperazin-1-yl)acetohydrazide
- N2-[2-Hydroxy-3-(2-propenyl)benzylidene]-4-benzylpiperazine-1-acetohydrazide
- (4-Benzylpiperazino)acetic acid (3-allyl-2-hyroxybenzylidene)hydrazide 1-Piperazineacetic acid
- (E)-N'-((5-allyl-6-oxocyclohexa-2,4-dien-1-ylidene)methyl)-2-(4-benzylpiperazin-1-yl)acetohydrazide
- 1-Piperazineacetic acid, 4-(phenylmethyl)-, (2E)-2-[[2-hydroxy-3-(2-propen-1-yl)phenyl]methylene]hydrazide
- 1-Piperazineacetic acid, 4-(phenylmethyl)-, 2-[[2-hydroxy-3-(2-propen-1-yl)phenyl]methylene]hydrazide
- 2-(4-benzylpiperazin-1-yl)-N'-((1E)-(2-hydroxy-3-(prop-2-en-1-yl)phenyl)methylidene)acetohydrazide
- 2-(4-benzylpiperazin-1-yl)-N'-[(6-oxo-5-prop-2-enylcyclohexa-2,4-dien-1-ylidene)methyl]acetohydrazide
- 2-(4-benzylpiperazin-1-yl)-N'-[(E)-(6-oxo-5-prop-2-enylcyclohexa-2,4-dien-1-ylidene)methyl]acetohydrazide
- 2-(4-Benzylpiperazin-1-yl)-N'-{(E)-[2-hydroxy-3-(prop-2-en-1-yl)phenyl]methylidene}acetohydrazide
- 2-(4-benzylpiperazin-1-yl)-N'-{[2-hydroxy-3-(prop-2-en-1-yl)phenyl]methylidene}acetohydrazide
- 2-[(E)-{2-[(4-benzylpiperazin-1-ium-1-yl)acetyl]hydrazinylidene}methyl]-6-(prop-2-en-1-yl)phenolate
- 4-(Phenylmethyl)-1-(piperazine-d8)acetic Acid (2E)-2-[[2-Hydroxy-3-(2-propen-1-yl)phenyl]methylene]hydrazide
- 4-(Phenylmethyl)-1-Piperazineacetic Acid-2-[[2-Hydroxy-3-(2-Allyl-1-Yl)Phenyl] Methylene] Hydrazide
- 636-533-6
- N'-[(6-oxo-5-prop-2-enyl-1-cyclohexa-2,4-dienylidene)methyl]-2-[4-(phenylmethyl)-1-piperazinyl]acetohydrazide